Long-Term Decrease in VLA-4 Expression and Functional Impairment of Dendritic Cells during Natalizumab Therapy in Patients with Multiple Sclerosis. de Andrés C, Teijeiro R, Alonso B, Sánchez-Madrid F, Martínez LM, de Villoria J G, Fernández-Cruz E, Sánchez-Ramón S PLoS One. 2012; 7(3):e34103. Epub 2012 Apr 04. PMID: 22496780. Abstract CommentRecommendBookmarkWatch